Abstract
In a prospective, randomized study at two university hospitals, the authors examined how effectively housestaff physicians (n=36) managed the initiation of warfarin therapy compared with a computer-assisted dosing regimen (n=39) using the software program Warfcalc, which was managed by one of the authors. Target prothrombin time ratios were selected by the physicians. Study endpoints included: the time to reach a therapeutic prothrombin ratio, the time to reach a stable therapeutic dose, the number of patients transiently overanticoagulated, the number of bleeding complications, and the accuracy of the predicted maintenance dose, which was assessed at steady-state 10–14 days later. Computer-assisted dosing consistently outperformed the physicians: a stable therapeutic dose was achieved 3.7 days earlier (p=0.002), fewer patients were overanticoagulated (10% versus 41%), and the predicted maintenance dose was in the therapeutic range in 85% of the computer-dosed patients versus 42% of the physician group (p<0.002). For physicians who did not routinely manage warfarin therapy, computer-assisted dosing improved the accuracy of dosing and shortened the time required to achieve a stable therapeutic dose.
Similar content being viewed by others
References
Wessler S, Gitel SN. Warfarin: from bedside to bench. N Engl J Med 1984;311:645–52
Hull R, Delmore T, Gentone E, et al. Warfarin sodium versus low-dose heparin in the long-term treatment of venous thrombosis. N Engl J Med 1979;301:855–8
Kelton JG, Hirsh J. Bleeding associated with antithrombotic therapy. Semin Hematol 1980;17:259–91
Forfar JC. Prediction of hemorrhage during long-term oral coumarin anticoagulation by excessive prothrombin ratio. Am Heart J 1982;103:445–6
Husted S, Andreasen F. Problems encountered in long-term treatment with anticoagulants. Acta Med Scand 1976;200:379–84
Fisher CM. Anticoagulant therapy in cerebral thrombosis and cerebral embolism. Neurology 1961;11:119–31
O’Reilly A, Aggeler PM. Determinants of the response to oral anticoagulant drugs in man. Pharmacol Rev 1970;22:35–96
Deykin D. Current status of anticoagulant therapy. Am J Med 1982;72:659–64
Brozovic M. Oral anticoagulants in clinical practice. Semin Hematol 1978;15:27–34
Koch-Weser J, Sellers EM. Drug interactions with coumarin anticoagulants. N Engl J Med 1971;285:547–57
Routledge PA, Davies DM, Bell SM, Cavanagh JS, Rawlins MD. Predicting patients’ warfarin requirements. Lancet 1977;ii:854–5
Miller DR, Brown MA. Predicting warfarin maintenance dosage based on initial response. Am J Hosp Pharm 1979;36:1351–5
Sawyer WT, Poe TE, Canaday BR, et al. Multicenter evaluation of six methods for predicting warfarin maintenance-dose requirements from initial response. Clin Pharm 1985;4:440–5
Fennerty A, Dolben J, Thomas P, et al. Flexible induction dose regimen for warfarin and prediction of maintenance dose. Br Med J 1984;228:1268–70
Wilson R, James AH. Computer assisted management of warfarin treatment. Br Med J 1984;289:422–4
Sawyer WT, Finn AL. Digital computer-assisted warfarin therapy: comparison of two models. Comput Biomed Res 1979;12:221–31
Theofanous TG, Barile RG. Multiple-dose kinetics of oral anticoagulants: methods of analysis and optimized dosing. J Pharmacol Sci 1973;62:261–6
Svec JM, Coleman RW, Mungall DR, Ludden TM. Bayesian pharmacokinetic/pharmacodynamic forecasting of prothrombin response to warfarin therapy: preliminary evaluation. Ther Drug Monit 1985;7:174–80
Sheiner LB, Beal S, Rosenberg B, Marathe VV. Forecasting individual pharmacokinetics. Clin Pharmacol Ther 1979;26:294–305
Mungall DR, Ludden TM, Marshall J, et al. Population pharmacokinetics of racemic warfarin. J Pharmacol Biopharm 1985;13:213–27
Sheiner LB, Rosenberg B, Marathe VV. Estimation of population characteristics of pharmacokinetic parameters from routine clinical data. J Pharmacokinet Biopharm 1977;5:445–78
Murray WE, McWaters DS, Coleman RW, Ludden TM, Mungall DA. Pharmacodynamics of warfarin. Clin Pharmacol Ther 1985;34:215 (abstr)
Sheiner LB, Beal SL. Some suggestions for measuring predictive performance. J Pharmacokinet Biopharm 1981;9:503–12
Pollock BE. Clinical experience with warfarin (Coumadin) sodium, a new anticoagulant. JAMA 1955;154:1094–7
O’Reilly A, Aggeler PM. Studies on coumarin anticoagulant drugs: initiation of warfarin therapy without a loading dose. Circulation 1968;38:169–77
Vozeh S, Muir KT, Sheiner LB, Follath F. Predicting individual phenytoin dosage. J Pharmacokinet Biopharm 1981;9:131–46
Kelman BW, Bryson S. OPT: a package of computer programs for parameter optimization in clinical pharmacokinetics. Br J Clin Pharmacol 1982;14:247–56
Hull R, Hirsh J, Jay R, et al. Different intensities of oral anticoagulant therapy in the treatment of proximal vein thrombosis. N Engl J Med 1982;307:1676–81
Simpson RJ. Warfcalc. Ann Intern Med 1985;103:973
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
White, R.H., Hong, R., Venook, A.P. et al. Initiation of warfarin therapy. J Gen Intern Med 2, 141–148 (1987). https://doi.org/10.1007/BF02596140
Issue Date:
DOI: https://doi.org/10.1007/BF02596140